Swedish Private Equity Firm Ratos To Buy Biolin Scientific

Swedish private equity firm Ratos has offered 11.50 kronor ($1.64) per share to buy Biolin Scientific. The offer represents a 32.2% premium over the average closing price for Biolin during the past 30 days. Sweden’s Biolin Scientific develops analytical instruments for research, development, quality control and clinical diagnostics.

DealsNorth AmericaUSBriefs